Relationships between exploratory eye movement dysfunction and clinical symptoms in schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 3, 2012, Pages 187-194

  Suzuki, Masahiro ^a   Takahashi, Sakae ^a   Matsushima, Eisuke ^b   Tsunoda, Masahiko ^d   Kurachi, Masayoshi ^d   Okada, Takashi ^e   Hayashi, Takuji ^f   Ishii, Yohei ^g   Morita, Kiichiro ^g   Maeda, Hisao ^h   Katayama, Seiji ⁱ   Otsuka, Tatsui ^j   Hirayasu, Yoshio ^j   Sekine, Mizuho ^c   Okubo, Yoshiro ^c   Motoshita, Mai ^b   Ohta, Katsuya ^b   Uchiyama, Makoto ^a   Kojima, Takuya ^k  

^a NIHON UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f Toyosato Hospital   (Japan)

^g KURUME UNIVERSITY   (Japan)

^h Wakahisa Hospital   (Japan)

ⁱ Yasugi Daiichi Hospital   (Japan)

^j YOKOHAMA CITY UNIVERSITY   (Japan)

^k Ohmiya Kosei Hospital   (Japan)

more..

Author keywords

biological marker; clinical symptoms of schizophrenia; exploratory eye movement; heterogeneity; schizophrenia

Indexed keywords

ADULT; ANXIETY; ARTICLE; ASYMPTOMATIC DISEASE; BLUNTED AFFECT; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; DISORIENTATION; EXCITEMENT; EXPLORATORY BEHAVIOR; EYE MOVEMENT DISORDER; EYE TRACKING; FEMALE; GESTURE; GUILT; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOTOR RETARDATION; SCHIZOPHRENIA; SYMPTOM; TENSION;

ADULT; ANTIPSYCHOTIC AGENTS; DATA INTERPRETATION, STATISTICAL; EXPLORATORY BEHAVIOR; EYE MOVEMENTS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; OCULAR MOTILITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84859027720     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02314.x     Document Type: Article

References (50)

1. Braff DL,. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 1993; 19: 233-259. (Pubitemid 23183147)
2. Szymanski S, Kane JM, Lieberman JA,. A selective review of biological markers in schizophrenia. Schizophr. Bull. 1991; 17: 99-111.
3. Bharath S, Gangadhar BN, Janakiramaiah N,. P300 in family studies of schizophrenia: Review and critique. Int. J. Psychophysiol. 2000; 38: 43-54.
4. Potter D, Summerfelt A, Gold J, Buchanan RW,. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr. Bull. 2006; 32: 692-700. (Pubitemid 44412856)
5. Devrim-Ucok M, Keskin-Ergen HY, Ucok A,. Mismatch negativity at acute and post-acute phases of first-episode schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2008; 258: 179-185. (Pubitemid 351642155)
6. Michie PT,. What has MMN revealed about the auditory system in schizophrenia? Int. J. Psychophysiol. 2001; 42: 177-194. (Pubitemid 32928383)
7. Parwani A, Duncan EJ, Bartlett E, et al,. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol. Psychiatry 2000; 47: 662-669. (Pubitemid 30169261)
8. Weike AI, Bauer U, Hamm AO,. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol. Psychiatry 2000; 47: 61-70. (Pubitemid 30016081)
9. Fukushima J, Fukushima K, Chiba T, Tanaka S, Yamashita I, Kato M,. Disturbances of voluntary control of saccadic eye movements in schizophrenic patients. Biol. Psychiatry 1988; 23: 670-677. (Pubitemid 18086646)
10. Haraldsson HM, Ettinger U, Magnusdottir BB, Sigmundsson T, Sigurdsson E, Petursson H,. Eye movement deficits in schizophrenia: Investigation of a genetically homogenous Icelandic sample. Eur. Arch. Psychiatry Clin. Neurosci. 2008; 258: 373-383.
11. Levy DL, Holzman PS, Matthysse S, Mendell NR,. Eye tracking and schizophrenia: A selective review. Schizophr. Bull. 1994; 20: 47-62. (Pubitemid 24071092)
12. Sereno AB, Holzman PS,. Antisaccades and smooth pursuit eye movements in schizophrenia. Biol. Psychiatry 1995; 37: 394-401.
13. Barrantes-Vidal N, Aguilera M, Campanera S, et al,. Working memory in siblings of schizophrenia patients. Schizophr. Res. 2007; 95: 70-75. (Pubitemid 47313656)
14. Goldman-Rakic PS,. The physiological approach: Functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry 1999; 46: 650-661. (Pubitemid 29401861)
15. Braff DL, Freedman R, Schork NJ, Gottesman II,. Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 2007; 33: 21-32. (Pubitemid 46026257)
16. Egan MF, Goldberg TE, Kolachana BS, et al,. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA 2001; 98: 6917-6922. (Pubitemid 32538317)
17. Kojima T, Matsushima E, Ando K, et al,. Exploratory eye movements and neuropsychological tests in schizophrenic patients. Schizophr. Bull. 1992; 18: 85-94.
18. Kojima T, Matsushima E, Iwama H, et al,. Visual perception process in amphetamine psychosis and schizophrenia. Psychopharmacol. Bull. 1986; 22: 768-773. (Pubitemid 17183380)
19. Kojima T, Matsushima E, Nakajima K, et al,. Eye movements in acute, chronic, and remitted schizophrenics. Biol. Psychiatry 1990; 27: 975-989. (Pubitemid 20134209)
20. Kojima T, Matsushima E, Ohta K, et al,. Stability of exploratory eye movements as a marker of schizophrenia: A WHO multi-center study. Schizophr. Res. 2001; 52: 203-213. (Pubitemid 33052510)
21. Kojima T, Potkin SG, Kharazmi M, Matsushima E, Herrera J, Shimazono Y,. Limited eye movement patterns in chronic schizophrenic patients. Psychiatry Res. 1989; 28: 307-314. (Pubitemid 19165771)
22. Matsukawa Y, Takahashi S, Aoki M, et al,. Patients with systemic lupus erythematosus show a normal responsive search score in exploratory eye movement analysis: Comparison with schizophrenia. Ann. Rheum. Dis. 2002; 61: 748-750. (Pubitemid 34787718)
23. Matsushima E, Kojima T, Ohbayashi S, Ando H, Ando K, Shimazono Y,. Exploratory eye movements in schizophrenic patients and patients with frontal lobe lesions. Eur. Arch. Psychiatry Clin. Neurosci. 1992; 241: 210-214.
24. Obayashi S, Matsushima E, Okubo Y, Ohkura T, Kojima T, Kakuma T,. Relationship between exploratory eye movements and clinical course in schizophrenic patients. Eur. Arch. Psychiatry Clin. Neurosci. 2001; 251: 211-216. (Pubitemid 34028475)
25. Tonoya Y, Matsui M, Kurachi M, Kurokawa K, Sumiyoshi T,. Exploratory eye movements in schizophrenia: Effects of figure size and the instruction on visual search. Eur. Arch. Psychiatry Clin. Neurosci. 2002; 252: 255-261. (Pubitemid 36227529)
26. Takahashi S, Matsushima E, Kojima T, Tanabe E, Yara K, Hagiwara M,. Study of the families and twins of schizophrenics. In:, Kojima T, Matsushima E, Ando K, (eds). Eyes and the Mind. Karger, Basel, 2000; 75-79.
27. Takahashi S, Tanabe E, Yara K, Matsuura M, Matsushima E, Kojima T,. Impairment of exploratory eye movement in schizophrenia patients and their siblings. Psychiatry Clin. Neurosci. 2008; 62: 487-493.
28. Takahashi S, Ohtsuki T, Yu SY, et al,. Significant linkage to chromosome 22q for exploratory eye movement dysfunction in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003; 123: 27-32. (Pubitemid 37323260)
29. Arinami T,. Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia. J. Hum. Genet. 2006; 51: 1037-1045. (Pubitemid 44800721)
30. Kirov G, O'Donovan MC, Owen MJ,. Finding schizophrenia genes. J. Clin. Invest. 2005; 115: 1440-1448. (Pubitemid 40814648)
31. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241.
32. Suzuki M, Takahashi S, Matsushima E, et al,. Exploratory eye movement dysfunction as a discriminator for schizophrenia: A large sample study using a newly developed digital computerized system. Eur. Arch. Psychiatry Clin. Neurosci. 2009; 259: 186-194.
33. Sawa A, Snyder SH,. Schizophrenia: Diverse approaches to a complex disease. Science 2002; 296: 692-695. (Pubitemid 34441987)
34. Takahashi S, Faraone SV, Lasky-Su J, Tsuang MT,. Genome-wide scan of homogeneous subtypes of NIMH genetics initiative schizophrenia families. Psychiatry Res. 2005; 133: 111-122. (Pubitemid 40312145)
35. Tsuang M,. Schizophrenia: Genes and environment. Biol. Psychiatry 2000; 47: 210-220. (Pubitemid 30077397)
36. Tsuang MT, Faraone SV,. The case for heterogeneity in the etiology of schizophrenia. Schizophr. Res. 1995; 17: 161-175.
37. Tsuang MT, Lyons MJ, Faraone SV,. Heterogeneity of schizophrenia. Conceptual models and analytic strategies. Br. J. Psychiatry 1990; 156: 17-26. (Pubitemid 20028147)
38. World Health Organization. The International Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva, 1993.
39. Overall JE, Gorham DR,. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799-812.
40. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. Part 18: Dose equivalence of psychotropic drugs: 2006-version. Jpn. J. Clin. Psychopharmacol. 2006; 9: 1443-1447 (in Japanese).
41. Klingberg S, Wittorf A, Wiedemann G,. Disorganization and cognitive impairment in schizophrenia: Independent symptom dimensions? Eur. Arch. Psychiatry Clin. Neurosci. 2006; 256: 532-540. (Pubitemid 46020527)
42. Lancon C, Auquier P, Nayt G, Reine G,. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr. Res. 2000; 42: 231-239. (Pubitemid 30216534)
43. Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C,. Psychopathological syndromes of schizophrenia: Evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophr. Bull. 2000; 26: 167-177. (Pubitemid 30317703)
44. Emsley R, Rabinowitz J, Torreman M, Group R-I-EPGW. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr. Res. 2003; 61: 47-57. (Pubitemid 36332139)
45. Lindenmayer JP, Grochowski S, Hyman RB,. Five factor model of schizophrenia: Replication across samples. Schizophr. Res. 1995; 14: 229-234.
46. Marder SR, Davis JM, Chouinard G,. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J. Clin. Psychiatry 1997; 58: 538-546. (Pubitemid 28100274)
47. Wolthaus JE, Dingemans PM, Schene AH, et al,. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology (Berl.) 2000; 150: 399-403. (Pubitemid 30470218)
48. Kay SR, Opler LA, Fiszbein A,. Positive and Negative Syndrome Scale (PANSS) Rating Manual. Multi-Health Systems, Toronto, 1991.
49. Lykouras L, Oulis P, Daskalopoulou E, et al,. Clinical subtypes of schizophrenic disorders: A cluster analytic study. Psychopathology 2001; 34: 23-28. (Pubitemid 32041451)
50. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; DSM-IV-TR. American Psychiatric Association, Washington DC, 2000.